HOFFMANN-LA ROCHE INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology MATTERS Rank in Class
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 577 18
 
 
C07D HETEROCYCLIC COMPOUNDS 478 10
 
 
C07K PEPTIDES 272 7
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 93 107
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 70 98
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 60 79
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 56 46
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 44 11
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 33 60
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 28 96
  • No Technologies to Display

Top Patents (by citation)

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0029,978 PROCESS FOR MAKING LYSINE-GLUTAMIC ACID DIPEPTIDE DERIVATIVES Oct 11, 17 Feb 01, 18 [C07C]
2018/0029,996 BICYCLIC QUINAZOLINONE DERIVATIVES Oct 10, 17 Feb 01, 18 [C07D]
2018/0024,115 SCREENING METHOD Feb 19, 16 Jan 25, 18 [A61K, G01N]
2018/0027,639 METHOD AND APPARATUS FOR ELECTROSTATICALLY DISCHARGING A PRIMARY PACKAGING CONTAINER MADE OF PLASTICS Sep 29, 17 Jan 25, 18 [H05F]
2018/0017,572 ASSAY AND METHOD FOR DETERMINING CDC ELICITING ANTIBODIES Jun 16, 17 Jan 18, 18 [G01N]
2018/0009,878 MULTISTEP FINAL FILTRATION Feb 27, 17 Jan 11, 18 [C07K]
2018/0010,162 FEED MIXING DEVICE AND ITS USE Sep 22, 17 Jan 11, 18 [C12N, C12M, C12P, B01F, C07K]
2018/0000,824 COMBINED TREATMENT WITH A TLR7 AGONIST AND AN HBV CAPSID ASSEMBLY INHIBITOR Sep 15, 17 Jan 04, 18 [A61K]
2018/0000,931 METHODS OF TREATING CEA-POSITIVE CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND ANTI-CEA/ANTI-CD3 BISPECIFIC ANTIBODIES Jan 05, 17 Jan 04, 18 [A61K, C07K]
2018/0002,333 ETHYNYL DERIVATIVES Sep 18, 17 Jan 04, 18 [C07D]

View all publication…

  • No Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9877963 GlyT1 inhibitors for use in the treatment of hematological disorders Oct 26, 16 Jan 30, 18 [A61P, A61K]
9879085 Antibodies against human CSF-1R and uses thereof Apr 17, 17 Jan 30, 18 [A61K, C07K]
9879095 Bispecific antibodies comprising a disulfide stabilized-Fv fragment Feb 21, 13 Jan 30, 18 [A61K, C07K]
9880135 Automatically controlling a plurality of devices of a separation and detection process for quantitative sample analysis Jun 17, 13 Jan 30, 18 [G01N]
9868766 Peptides as oxytocin agonists Jun 18, 15 Jan 16, 18 [A61K, C07K]
9862763 Humanized anti-tau(pS422) antibodies and methods of use Jun 22, 16 Jan 09, 18 [A61K, C07K]
9862779 Method for the production and selection of molecules comprising at least two different entities and uses thereof Mar 13, 15 Jan 09, 18 [C12N, C07K]
9856247 4-methyl-dihydropyrimidines for the treatment and prophylaxis of Hepatitis B virus infection Aug 28, 15 Jan 02, 18 [C07D]
9845322 Tetrahydropyridopyrimidines and tetrahydropyridopyridines for the treatment and prophylaxis of hepatitis B virus infection May 03, 16 Dec 19, 17 [C07D]
9845347 Alkaline feed Jan 28, 15 Dec 19, 17 [C12N, C07H, C12P, C07K]

View all Patent…

  • No Patents to Display

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0266,286 NOVEL PHARMACEUTICAL DOSAGE FORMS COMPRISING VALGANCICLOVIR HYDROCHLORIDE ABAN Apr 05, 17 Sep 21, 17 [A61K]
2017/0081,312 ANTIVIRAL COMPOUNDS ABAN Dec 06, 16 Mar 23, 17 [C07D, A61K]
2017/0008,901 SPIRO-OXAZOLONES ABAN Jun 06, 16 Jan 12, 17 [C07D]
2016/0333,414 IDENTIFICATION OF PATIENTS IN NEED OF PD-L1 INHIBITOR COTHERAPY ABAN May 22, 15 Nov 17, 16 [C12Q, A61K, G01N]
2016/0272,626 PYRAZINE DERIVATIVES ABAN Nov 04, 13 Sep 22, 16 [C07D]
2016/0257,749 ANTI-TIM3 ANTIBODIES AND METHODS OF USE ABAN Nov 06, 15 Sep 08, 16 [A61K, C07K]
2016/0256,529 COMBINATION THERAPY ABAN Mar 07, 16 Sep 08, 16 [A61K]
2016/0220,669 COMBINATION THERAPY OF ANTIBODIES AGAINST HUMAN CSF-1R AND TLR9 AGONIST ABAN Oct 16, 15 Aug 04, 16 [A61K, C07K]
2016/0207,890 ETHYNYL DERIVATIVES ABAN Mar 25, 16 Jul 21, 16 [C07D]
2016/0200,672 NEW PROCESS ABAN Mar 22, 16 Jul 14, 16 [C07C]
2016/0200,741 Novel indazoles for the treatment and prophylaxis of respiratory syncytial virus infection ABAN Nov 18, 15 Jul 14, 16 [C07D]
2016/0168,253 THERAPEUTIC FUSION PROTEIN ABAN Jul 30, 14 Jun 16, 16 [C12N, C07K]
2016/0159,912 COMBINATION THERAPY OF ANTI-HER3 ANTIBODIES ABAN Oct 07, 15 Jun 09, 16 [C07K]
9290451 Pyridine derivatives as agonists of the CB2 receptor Withdrawn Jun 01, 12 Mar 22, 16 [C07D]
2016/0074,360 COMBINED DRUG ADMINISTRATION OF DALCETRAPIB AND ORLISTAT ABAN Nov 05, 15 Mar 17, 16 [A61K]
2016/0045,597 COMBINATION THERAPY OF ANTIBODIES ACTIVATING HUMAN CD40 AND ANTIBODIES AGAINST HUMAN PD-L1 ABAN Aug 14, 15 Feb 18, 16 [A61K]
2016/0031,878 RADIOLABELED COMPOUNDS ABAN Jul 30, 15 Feb 04, 16 [C07D, C07B, A61K]
2015/0361,034 NEW PROCESS ABAN Aug 20, 15 Dec 17, 15 [C07C]
2015/0353,559 NEW BICYCLIC DERIVATIVES ABAN May 21, 15 Dec 10, 15 [C07D]
2015/0353,640 ANTIBODY FORMULATION ABAN Jan 29, 14 Dec 10, 15 [A61K, C07K]

View all Patent…

  • No Patents to Display

Top Inventors for This Owner

We are sorry but your current selection exceeds the maximum number of watches () for this membership level. Upgrade to our Level for up to watches!

Owner Watch
HOFFMANN-LA ROCHE INC.
CANCEL
UPGRADE MEMBERSHIP CANCEL

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to comparisons!

UPGRADE MEMBERSHIP CANCEL

We are sorry but your current selection exceeds the maximum number of portfolios () for this membership level. Upgrade to our Level for up to portfolios!

UPGRADE MEMBERSHIP CANCEL

We are sorry but your current selection exceeds the maximum number of patents allowed in portfolios () for this membership level. Upgrade to our Level for up to patents!

UPGRADE MEMBERSHIP CANCEL